Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Di Stefano, Anna Luisa, Fucci, Alessandra, Frattini, Veronique, Labussiere, Marianne, Mokhtari, Karima, Zoppoli, Pietro, Marie, Yannick, Bruno, Aurelie, Boisselier, Blandine, Giry, Marine, Savatovsky, Julien, Touat, Mehdi, Belaid, Hayat, Kamoun, Aurelie, Idbaih, Ahmed, Houillier, Caroline, Luo, Feng R, Soria, Jean-Charles, Tabernero, Josep, Eoli, Marica, Paterra, Rosina, Yip, Stephen, Petrecca, Kevin, Chan, Jennifer A, Finocchiaro, Gaetano, Lasorella, Anna, Sanson, Marc, Iavarone, Antonio
Published in Clinical cancer research (15.07.2015)
Published in Clinical cancer research (15.07.2015)
Get full text
Journal Article
Dasatinib (BMS-354825) Pharmacokinetics and Pharmacodynamic Biomarkers in Animal Models Predict Optimal Clinical Exposure
LUO, Feng R, ZHENG YANG, WEN, Mei-Li, KRAMER, Robert, BLACKWOOD-CHIRCHIR, Anne, LEE, Francis Y, CAMUSO, Amy, SMYKLA, Richard, MCGLINCHEY, Kelly, FAGER, Krista, FLEFLEH, Christine, CASTANEDA, Stephen, INIGO, Ivan, KAN, David
Published in Clinical cancer research (01.12.2006)
Published in Clinical cancer research (01.12.2006)
Get full text
Journal Article
Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring
Wang, Xi-De, Reeves, Karen, Luo, Feng R, Xu, Li-An, Lee, Francis, Clark, Edwin, Huang, Fei
Published in Genome biology (01.01.2007)
Published in Genome biology (01.01.2007)
Get full text
Journal Article
Preclinical Antitumor Activity of BMS-599626, a pan-HER Kinase Inhibitor That Inhibits HER1/HER2 Homodimer and Heterodimer Signaling
WONG, Tai W, LEE, Francis Y, GAVAI, Ashvinikumar V, VITE, Gregory D, YU, Chiang, LUO, Feng R, OPPENHEIMER, Simone, HONGJIAN ZHANG, SMYKLA, Richard A, MASTALERZ, Harold, FINK, Brian E, HUNT, John T
Published in Clinical cancer research (15.10.2006)
Published in Clinical cancer research (15.10.2006)
Get full text
Journal Article
Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
Tabernero, Josep, Bahleda, Rastislav, Dienstmann, Rodrigo, Infante, Jeffrey R, Mita, Alain, Italiano, Antoine, Calvo, Emiliano, Moreno, Victor, Adamo, Barbara, Gazzah, Anas, Zhong, Bob, Platero, Suso J, Smit, Johan W, Stuyckens, Kim, Chatterjee-Kishore, Moitreyee, Rodon, Jordi, Peddareddigari, Vijay, Luo, Feng R, Soria, Jean-Charles
Published in Journal of clinical oncology (20.10.2015)
Published in Journal of clinical oncology (20.10.2015)
Get full text
Journal Article
Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib
Karkera, Jayaprakash D, Cardona, Gabriela Martinez, Bell, Katherine, Gaffney, Dana, Portale, Joseph C, Santiago-Walker, Ademi, Moy, Christopher H, King, Peter, Sharp, Michael, Bahleda, Rastislav, Luo, Feng R, Alvarez, John D, Lorenzi, Matthew V, Platero, Suso J
Published in Molecular cancer therapeutics (01.08.2017)
Published in Molecular cancer therapeutics (01.08.2017)
Get full text
Journal Article
Membrane transport of camptothecin: facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2)
Lalloo, Anita K, Luo, Feng R, Guo, Ailan, Paranjpe, Pankaj V, Lee, Sung-Hack, Vyas, Viral, Rubin, Eric, Sinko, Patrick J
Published in BMC medicine (04.05.2004)
Published in BMC medicine (04.05.2004)
Get full text
Journal Article
Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors
Johnson, Faye M., Agrawal, Shruti, Burris, Howard, Rosen, Lee, Dhillon, Navneet, Hong, David, Blackwood‐Chirchir, Anne, Luo, Feng R., Sy, Oumar, Kaul, Sanjeev, Chiappori, Alberto A.
Published in Cancer (15.03.2010)
Published in Cancer (15.03.2010)
Get full text
Journal Article
Prediction of Active Drug Plasma Concentrations Achieved in Cancer Patients by Pharmacodynamic Biomarkers Identified from the Geo Human Colon Carcinoma Xenograft Model
LUO, Feng R, ZHENG YANG, WONG, Tai W, KRAMER, Robert A, WILD, Robert, LEE, Francis Y, HUIJIN DONG, CAMUSO, Amy, MCGLINCHEY, Kelly, FAGER, Krista, FLEFLEH, Christine, KAN, David, INIGO, Ivan, CASTANEDA, Stephen
Published in Clinical cancer research (01.08.2005)
Published in Clinical cancer research (01.08.2005)
Get full text
Journal Article
Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects
Eley, Timothy, Luo, Feng R, Agrawal, Shruti, Sanil, Ashish, Manning, James, Li, Tong, Blackwood-Chirchir, Anne, Bertz, Richard
Published in Journal of clinical pharmacology (01.06.2009)
Published in Journal of clinical pharmacology (01.06.2009)
Get more information
Journal Article
Oxaliplatin biotransformation and pharmacokinetics: a pilot study to determine the possible relationship to neurotoxicity
Shord, Stacy S, Bernard, Stephen A, Lindley, Celeste, Blodgett, Andrew, Mehta, Viral, Churchel, Mary Ann, Poole, Michael, Pescatore, Scott L, Luo, Feng R, Chaney, Stephen G
Published in Anticancer research (01.07.2002)
Get more information
Published in Anticancer research (01.07.2002)
Journal Article
Biotransformations of oxaliplatin in rat blood in vitro
Luo, Feng R., Wyrick, Steven D., Chaney, Stephen G.
Published in Journal of biochemical and molecular toxicology (1999)
Published in Journal of biochemical and molecular toxicology (1999)
Get full text
Journal Article
Prodrugs of protein tyrosine kinase inhibitors
LEE FRANCIS Y, KIM KYOUNG S, WITYAK JOHN, LUO FENG R, LOMBARDO LOUIS J
Year of Publication 30.03.2006
Get full text
Year of Publication 30.03.2006
Patent